Related Experiment Video
Updated: Aug 7, 2026
11:02
Isolation and Physiological Analysis of Mouse Cardiomyocytes
Published on: September 7, 2014
Thyrotoxicosis and the heart
1Department of Medicine, Mount Zion Medical Center, University of California, San Francisco 94115.
The New England Journal of Medicine
|July 9, 1992
Summary
Excess thyroid hormone (thyrotoxicosis) significantly impacts the cardiovascular system, potentially causing serious heart conditions. Prompt diagnosis and treatment of thyrotoxicosis are crucial for managing cardiac symptoms and restoring normal heart function.
Area of Science:
- Endocrinology
- Cardiology
Background:
- Thyrotoxicosis, characterized by excess thyroid hormone, frequently presents with cardiovascular manifestations.
- These effects can exacerbate existing heart conditions or precipitate new ones like atrial fibrillation and heart failure.
Purpose of the Study:
- To highlight the significant cardiovascular impact of thyrotoxicosis.
- To emphasize the importance of considering thyrotoxicosis in patients with cardiac symptoms, especially the elderly.
Main Methods:
- Clinical observation and analysis of patient presentations.
- Review of the effects of excess thyroid hormone on cardiac function.
Main Results:
- Cardiovascular symptoms, including atrial fibrillation, congestive heart failure, and angina, are common in thyrotoxicosis.
- In elderly individuals, cardiac issues may be the primary presentation of thyrotoxicosis.
- Serum thyrotropin levels are important for diagnosis in these cases.
Conclusions:
- Thyrotoxicosis poses a significant risk to cardiovascular health.
- Management of thyrotoxicosis typically resolves cardiac dysfunction if no prior heart disease exists.
- Early diagnosis and treatment are essential for preventing and managing thyrotoxicosis-related cardiac complications.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...